1. under 18 years 2. known hypersensitivity to the active ingredient or any of the drug's excipients. 3. known history of heart failure or situation at the time of initiation of the heart failure study. 4. hepatic failure. 5. dialysis 6. situation of diabetic ketoacidosis at the start of the study. 7. diabetes mellitus different from type 2. 8. active bladder cancer or a history of bladder cancer 9. hematuria 10. patients included in another experimental study with another drug. 11. admission to the intensive care unit. 12. patients requiring mechanical ventilation at the time of inclusion 13. pregnancy 14. lactation

1. under 18 years 2. known hypersensitivity to the active ingredient or any of the drug's excipients. 3. known history of heart failure or situation at the time of initiation of the heart failure study. 4. hepatic failure. 5. dialysis 6. situation of diabetic ketoacidosis at the start of the study. 7. diabetes mellitus different from type 2. 8. active bladder cancer or a history of bladder cancer 9. hematuria 10. patients included in another experimental study with another drug. 11. admission to the intensive care unit. 12. patients requiring mechanical ventilation at the time of inclusion 13. pregnancy 14. lactation

under 18 years known hypersensitivity to the active ingredient or any of the drug's excipients. known history of heart failure or situation at the time of initiation of the heart failure study. hepatic failure. dialysis situation of diabetic ketoacidosis at the start of the study. diabetes mellitus different from type 2. active bladder cancer or a history of bladder cancer hematuria patients included in another experimental study with another drug. admission to the intensive care unit. patients requiring mechanical ventilation at the time of inclusion pregnancy lactation

under 18 years known hypersensitivity to the active ingredient or any of the drug's excipients. known history of heart failure or situation at the time of initiation of the heart failure study. hepatic failure. dialysis situation of diabetic ketoacidosis at the start of the study. diabetes mellitus different from type 2. active bladder cancer or a history of bladder cancer hematuria patients included in another experimental study with another drug. admission to the intensive care unit. patients requiring mechanical ventilation at the time of inclusion pregnancy lactation

1. under 18 years 2. known hypersensitivity to the active ingredient or any of the drug's excipients. 3. known history of heart failure or situation at the time of initiation of the heart failure study. 4. hepatic failure. 5. dialysis 6. situation of diabetic ketoacidosis at the start of the study. 7. diabetes mellitus different from type 2. 8. active bladder cancer or a history of bladder cancer 9. hematuria 10. patients included in another experimental study with another drug. 11. admission to the intensive care unit. 12. patients requiring mechanical ventilation at the time of inclusion 13. pregnancy 14. lactation

1. under 18 years 2. known hypersensitivity to the active ingredient or any of the drug's excipients. 3. known history of heart failure or situation at the time of initiation of the heart failure study. 4. hepatic failure. 5. dialysis 6. situation of diabetic ketoacidosis at the start of the study. 7. diabetes mellitus different from type 2. 8. active bladder cancer or a history of bladder cancer 9. hematuria 10. patients included in another experimental study with another drug. 11. admission to the intensive care unit. 12. patients requiring mechanical ventilation at the time of inclusion 13. pregnancy 14. lactation